San Clemente, CA, United States of America

Sum Chan

This inventor holds 24 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Quest Diagnostics Investments, Inc., Quest Diagnostics Investment Incoporated. Active years: 2011-2026.

USPTO Granted Patents = 24 

% Patents Active = 95.8


 

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Sum Chan

Introduction: Sum Chan, a talented inventor based in San Clemente, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Sum Chan holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: Throughout his career, Sum Chan has demonstrated a remarkable ability to transform complex concepts into practical solutions. His innovative approach has led to the development of cutting-edge technologies that have improved efficiency and effectiveness in multiple industries.

Collaborations: Sum Chan has collaborated with leading research institutions and tech companies to further advance his inventions. His partnerships have resulted in the successful implementation of his ideas in real-world applications, benefiting both businesses and consumers.

Conclusion: Sum Chan's passion for innovation and his dedication to pushing the boundaries of technology have established him as a respected figure in the inventor community. His relentless pursuit of excellence continues to inspire others to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…